Could we use a lower dose of rituximab to treat rheumatoid arthritis in clinical practice: pros and cons?
Crossref DOI link: https://doi.org/10.1186/s13075-016-1022-1
Published Online: 2016-06-02
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ferraccioli, Gianfranco
Tolusso, Barbara
Gremese, Elisa
